2022. Efficacy and Tolerability of Valganciclovir 6 Months vs 6 Weeks in Symptomatic Cytomegalovirus Infection in Infants: An Open Level Randomized Controlled Trial. European Journal of Clinical Medicine. 3, 1 (Jan. 2022), 18–25. DOI:https://doi.org/10.24018/clinicmed.2022.3.1.122.